Genes regulated in MPTP-treated macaques and human Parkinson's disease suggest a common signature in prefrontal cortex
暂无分享,去创建一个
Qin Li | E. Bézard | B. Bioulac | C. Gross | M. Arguel | A. Vital | G. Wong | J. Nahon | M. Storvik | S. Schmieder | C. Qin | Audrey Delerue-Audegond
[1] E. Bézard,et al. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms , 2009, The Lancet Neurology.
[2] Erwan Bezard,et al. Sleep disorders in Parkinson's disease: The contribution of the MPTP non-human primate model , 2009, Experimental Neurology.
[3] H. Reichmann,et al. Beyond tremor and rigidity: non-motor features of Parkinson’s disease , 2009, Journal of Neural Transmission.
[4] A. Bittner,et al. Dopamine Depletion Induces Distinct Compensatory Gene Expression Changes in DARPP-32 Signal Transduction Cascades of Striatonigral and Striatopallidal Neurons , 2009, The Journal of Neuroscience.
[5] H. Bergman,et al. Pathophysiology of the basal ganglia and movement disorders: From animal models to human clinical applications , 2008, Neuroscience & Biobehavioral Reviews.
[6] C. Da Cunha,et al. Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease , 2008, Neuroscience.
[7] B. Bioulac,et al. A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France , 2007, Movement disorders : official journal of the Movement Disorder Society.
[8] V. Dhawan,et al. Changes in network activity with the progression of Parkinson's disease. , 2007, Brain : a journal of neurology.
[9] L. Moran,et al. Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson’s disease , 2006, Neurogenetics.
[10] P. Hevezi,et al. Gene expression analyses reveal molecular relationships among 20 regions of the human CNS , 2006, Neurogenetics.
[11] D. Hansel,et al. Competition between Feedback Loops Underlies Normal and Pathological Dynamics in the Basal Ganglia , 2022 .
[12] E. Bézard,et al. Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's disease , 2005, Neurobiology of Disease.
[13] Howard J Federoff,et al. Dysregulation of Gene Expression in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Substantia Nigra , 2004, The Journal of Neuroscience.
[14] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[15] Claude Ghez,et al. Learning networks in health and Parkinson's disease: Reproducibility and treatment effects , 2003, Human brain mapping.
[16] E. Bézard,et al. Microarray analysis of nonhuman primates: validation of experimental models in neurological disorders , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] Erwan Bezard,et al. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated , 2003, Trends in Neurosciences.
[18] P. Strick,et al. Basal-ganglia 'projections' to the prefrontal cortex of the primate. , 2002, Cerebral cortex.
[19] S. Leurgans,et al. Loss of basal forebrain P75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease , 2002, The Journal of comparative neurology.
[20] B Bioulac,et al. Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease , 2001, The Journal of Neuroscience.
[21] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[22] E. Bézard,et al. Upregulation of Striatal Preproenkephalin Gene Expression Occurs before the Appearance of Parkinsonian Signs in 1-Methyl-4-phenyl- 1,2,3,6-tetrahydropyridine Monkeys , 2001, Neurobiology of Disease.
[23] E. Bézard,et al. Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] G. Wilcock,et al. Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease. , 1999, Biochemical and biophysical research communications.
[25] E. Tolosa,et al. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. , 1999, Journal of neuropathology and experimental neurology.
[26] E. Bézard,et al. Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms , 1999, The European journal of neuroscience.
[27] E. Bézard,et al. Compensatory mechanisms in experimental and human Parkinsonism: towards a dynamic approach , 1998, Progress in Neurobiology.
[28] Douglas M. Bowden,et al. A Stereotaxic Template Atlas of the Macaque Brain for Digital Imaging and Quantitative Neuroanatomy , 1996, NeuroImage.
[29] Mark W. Mahowald,et al. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder , 1996, Neurology.
[30] T. Ishikawa,et al. The Metabolic Topography of Parkinsonism , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[31] O. Hornykiewicz,et al. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey , 1991, Neuroscience.
[32] A. Grace,et al. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications , 1990, Trends in Neurosciences.
[33] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[34] W. Cowan,et al. A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis) , 1984, The Journal of comparative neurology.
[35] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[36] E. Hirsch,et al. Neuronal vulnerability in Parkinson's disease. , 1997, Journal of neural transmission. Supplementum.
[37] G. E. Alexander,et al. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.